These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers. Park PW; Casiano EM; Escoto L; Claveria AM Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412 [TBL] [Abstract][Full Text] [Related]
4. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511 [TBL] [Abstract][Full Text] [Related]
5. Nonsmoking after simultaneous alcohol abstinence and smoking cessation program was associated with better drinking status outcome in Japanese alcohol-dependent men: A prospective follow-up study. Yokoyama A; Kimura M; Yoshimura A; Matsushita S; Yoneda J; Maesato H; Komoto Y; Nakayama H; Sakuma H; Yumoto Y; Takimura T; Toyama T; Iwahara C; Mizukami T; Yokoyama T; Higuchi S PLoS One; 2023; 18(3):e0282992. PubMed ID: 36989266 [TBL] [Abstract][Full Text] [Related]
6. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. Hurt RT; Ebbert JO; Croghan IT; Schroeder DR; Hurt RD; Hays JT Drug Alcohol Depend; 2018 Mar; 184():12-17. PubMed ID: 29324248 [TBL] [Abstract][Full Text] [Related]
7. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial. Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399 [TBL] [Abstract][Full Text] [Related]
8. Varenicline for smoking cessation: a placebo-controlled, randomized study. Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221 [TBL] [Abstract][Full Text] [Related]
9. Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study). Carson KV; Smith BJ; Brinn MP; Peters MJ; Fitridge R; Koblar SA; Jannes J; Singh K; Veale AJ; Goldsworthy S; Litt J; Edwards D; Hnin KM; Esterman AJ Nicotine Tob Res; 2014 Nov; 16(11):1495-502. PubMed ID: 25031315 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547 [TBL] [Abstract][Full Text] [Related]
11. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study. Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652 [TBL] [Abstract][Full Text] [Related]
13. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice. Wang C; Cho B; Xiao D; Wajsbrot D; Park PW Int J Clin Pract; 2013 May; 67(5):469-76. PubMed ID: 23574106 [TBL] [Abstract][Full Text] [Related]
17. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442 [TBL] [Abstract][Full Text] [Related]
18. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Saladin ME; McClure EA; Baker NL; Carpenter MJ; Ramakrishnan V; Hartwell KJ; Gray KM Nicotine Tob Res; 2015 Apr; 17(4):398-406. PubMed ID: 25762749 [TBL] [Abstract][Full Text] [Related]
19. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235 [TBL] [Abstract][Full Text] [Related]
20. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]